FFCP PHASE1:Hg19::chr3:46448386..46448406,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=9034 | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=gencodeV16_protein_coding | |||
|HGNC=1612 | |||
|TSSclassifier=weak | |||
|UniProt=O00421 | |||
|association_with_transcript=-247bp_to_ENST00000399036_5end | |||
|coexpression_cluster_id=C0 | |||
|description=CAGE_peak_7_at_CCRL2_5end | |||
|id=chr3:46448386..46448406,+ | |||
|ontology_enrichment_celltype=CL:0002057!7.21e-105!42;CL:0000860!1.47e-97!45;CL:0002009!4.44e-70!65;CL:0002194!3.70e-67!63;CL:0000576!3.70e-67!63;CL:0000040!3.70e-67!63;CL:0000559!3.70e-67!63;CL:0000557!7.94e-64!71;CL:0000839!4.69e-60!70;CL:0000766!5.41e-55!76;CL:0000763!7.57e-39!112;CL:0000049!7.57e-39!112;CL:0002087!3.16e-36!119;CL:0002031!1.25e-34!124;CL:0000738!1.58e-32!140;CL:0000037!1.51e-25!172;CL:0000566!1.51e-25!172;CL:0002032!8.30e-25!165;CL:0000837!8.30e-25!165;CL:0000988!7.26e-24!182;CL:0000134!1.61e-11!358;CL:0002320!3.41e-11!365;CL:0000219!4.88e-10!390;CL:0000048!1.18e-08!430;CL:0000723!1.87e-08!436;CL:0000034!3.35e-08!444 | |||
|ontology_enrichment_celltype_v019=CL:0000860;1.34e-117;33!CL:0002057;1.34e-117;33!CL:0000473;1.03e-81;39!CL:0000234;1.03e-81;39!CL:0000576;6.21e-52;48!CL:0000766;1.65e-29;69!CL:0002087;1.39e-15;104!CL:0000763;1.36e-14;100!CL:0000738;5.24e-08;136 | |||
|ontology_enrichment_celltype_v019_2=CL:0000860,4.25e-101,42;CL:0002057,4.25e-101,42;CL:0000473,3.98e-88,48;CL:0000234,3.98e-88,48;CL:0002194,5.89e-70,59;CL:0000576,5.89e-70,59;CL:0000040,5.89e-70,59;CL:0000559,5.89e-70,59;CL:0002009,1.31e-67,61;CL:0000839,2.33e-62,66;CL:0000557,2.12e-61,67;CL:0000766,5.28e-57,72;CL:0000763,3.11e-37,108;CL:0000049,3.11e-37,108;CL:0002087,8.22e-35,115;CL:0002031,2.98e-33,120;CL:0000738,5.04e-29,136;CL:0002032,4.40e-24,161;CL:0000837,4.40e-24,161;CL:0000037,5.84e-23,168;CL:0000988,1.21e-21,177;CL:0000134,2.93e-09,354;CL:0002320,5.13e-09,361;CL:0000219,3.71e-08,386;CL:0000048,4.21e-07,427;CL:0000723,5.89e-07,433;CL:0000034,9.09e-07,441 | |||
|ontology_enrichment_development_v019=CL:0002057;6.30e-73;42!CL:0000049;8.49e-10;108 | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0002371!3.50e-56!80;UBERON:0001474!5.80e-52!86;UBERON:0002390!2.02e-46!102;UBERON:0003061!2.02e-46!102;UBERON:0004765!1.39e-43!101;UBERON:0001434!1.39e-43!101;UBERON:0002193!7.31e-42!112;UBERON:0002405!1.04e-37!115;UBERON:0002204!1.89e-24!167;UBERON:0003081!2.68e-19!216;UBERON:0002384!9.54e-11!375;UBERON:0002171!2.31e-07!1;UBERON:0006518!2.31e-07!1;UBERON:0008949!2.31e-07!1;UBERON:0000101!2.31e-07!1;UBERON:0002167!2.31e-07!1;UBERON:0000926!2.92e-07!448;UBERON:0004120!2.92e-07!448;UBERON:0006603!2.92e-07!448 | |||
|ontology_enrichment_uberon_v019= | |||
|ontology_enrichment_uberon_v019_2=UBERON:0002371,6.75e-54,76;UBERON:0001474,8.50e-50,82;UBERON:0004765,3.61e-45,90;UBERON:0002405,1.23e-43,93;UBERON:0002390,2.75e-41,98;UBERON:0003061,2.75e-41,98;UBERON:0001434,2.06e-40,100;UBERON:0002193,3.11e-37,108;UBERON:0002204,4.09e-23,167;UBERON:0003081,1.71e-18,203;UBERON:0000926,8.25e-11,315;UBERON:0004120,8.25e-11,315;UBERON:0006603,8.25e-11,315;UBERON:0002384,1.10e-08,371 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.217010870715852,0,0,0,0,0,0,2.32429036905685,4.11167888021826,12.6979612066992,17.5492359316512,8.96562472851852,27.4319386670759,108.250143751298,80.0401007643944,200.431200159626,0.376484679085209,0.545812300115692,1.34834090667051,70.3992952453076,61.9393022256861,163.030967078756,0.659702600373432,0.398927315243264,0,41.2097118852589,37.4474248296152,84.0810036144026,2.26123798731069,1.0429658368404,4.99534342821768,40.5617666764357,90.2280208169533,169.940302055755,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.213455115606889,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.77380195455795,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.414239055347196,0,0,0,0,0,0.2506898940227,0.612691153526923,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p7@CCRL2 | |||
}} |
Revision as of 18:38, 21 January 2014
Short description: | p7@CCRL2 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | No |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_7_at_CCRL2_5end |
Coexpression cluster: | C0_CD14_Eosinophils_Neutrophils_Basophils_CD34_immature_Peripheral |
Association with transcript: | -247bp_to_ENST00000399036_5end |
EntrezGene: | CCRL2 |
HGNC: | 1612 |
UniProt: | O00421 |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
classical monocyte | 4.25e-101 | 42 |
CD14-positive, CD16-negative classical monocyte | 4.25e-101 | 42 |
defensive cell | 3.98e-88 | 48 |
phagocyte | 3.98e-88 | 48 |
monopoietic cell | 5.89e-70 | 59 |
monocyte | 5.89e-70 | 59 |
monoblast | 5.89e-70 | 59 |
promonocyte | 5.89e-70 | 59 |
macrophage dendritic cell progenitor | 1.31e-67 | 61 |
myeloid lineage restricted progenitor cell | 2.33e-62 | 66 |
granulocyte monocyte progenitor cell | 2.12e-61 | 67 |
myeloid leukocyte | 5.28e-57 | 72 |
myeloid cell | 3.11e-37 | 108 |
common myeloid progenitor | 3.11e-37 | 108 |
nongranular leukocyte | 8.22e-35 | 115 |
hematopoietic lineage restricted progenitor cell | 2.98e-33 | 120 |
leukocyte | 5.04e-29 | 136 |
hematopoietic oligopotent progenitor cell | 4.40e-24 | 161 |
hematopoietic multipotent progenitor cell | 4.40e-24 | 161 |
hematopoietic stem cell | 5.84e-23 | 168 |
hematopoietic cell | 1.21e-21 | 177 |
mesenchymal cell | 2.93e-09 | 354 |
connective tissue cell | 5.13e-09 | 361 |
motile cell | 3.71e-08 | 386 |
multi fate stem cell | 4.21e-07 | 427 |
somatic stem cell | 5.89e-07 | 433 |
stem cell | 9.09e-07 | 441 |
Ontology term | p-value | n |
---|---|---|
bone marrow | 6.75e-54 | 76 |
bone element | 8.50e-50 | 82 |
skeletal element | 3.61e-45 | 90 |
immune system | 1.23e-43 | 93 |
hematopoietic system | 2.75e-41 | 98 |
blood island | 2.75e-41 | 98 |
skeletal system | 2.06e-40 | 100 |
hemolymphoid system | 3.11e-37 | 108 |
musculoskeletal system | 4.09e-23 | 167 |
lateral plate mesoderm | 1.71e-18 | 203 |
mesoderm | 8.25e-11 | 315 |
mesoderm-derived structure | 8.25e-11 | 315 |
presumptive mesoderm | 8.25e-11 | 315 |
connective tissue | 1.10e-08 | 371 |